Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0250
-0.0024 (-8.76%)
At close: Nov 5, 2026
Emmaus Life Sciences Market Cap
Emmaus Life Sciences has a market cap or net worth of $1.75 million as of November 5, 2026. It is the 48,270th most valuable company in the world and the 6,441st biggest in the United States. Its market cap has increased by 195.43% in one year.
Market Cap
1.75M
Enterprise Value
29.46M
Revenue
15.53M
Global Rank
Country Rank
#6,441 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since July 18, 2019, Emmaus Life Sciences's market cap has decreased from 353.30M to 1.75M, a decrease of -99.50%. That is a compound annual growth rate of -51.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 1.75M | 111.35% |
| Dec 31, 2025 | 830.25K | 52.94% |
| Dec 31, 2024 | 542.86K | -91.23% |
| Dec 29, 2023 | 6.19M | -52.02% |
| Dec 30, 2022 | 12.90M | -84.34% |
| Dec 31, 2021 | 82.35M | 36.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GPL Holdings | 2.56M |
| Bioxytran | 2.42M |
| Vaccinex | 2.41M |
| America Great Health | 2.12M |
| Nymox Pharmaceutical | 2.10M |
| AccuStem Sciences | 2.09M |
| CASI Pharmaceuticals | 2.06M |
| Vaxxinity | 1.90M |